Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis

NCT04316442 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Light Chain (AL) Amyloidosis

Interventions

BIOLOGICAL: STI-6129

Sponsor

Sorrento Therapeutics, Inc.